292 related articles for article (PubMed ID: 17690039)
1. Promoter hypermethylation of death-associated protein kinase gene in cholangiocarcinoma.
Liu XF; Kong FM; Xu Z; Yu SP; Sun FB; Zhang CS; Huang QX; Zhou XT; Song ZW
Hepatobiliary Pancreat Dis Int; 2007 Aug; 6(4):407-11. PubMed ID: 17690039
[TBL] [Abstract][Full Text] [Related]
2. The methylation status of the TMS1/ASC gene in cholangiocarcinoma and its clinical significance.
Liu XF; Zhu SG; Zhang H; Xu Z; Su HL; Li SJ; Zhou XT
Hepatobiliary Pancreat Dis Int; 2006 Aug; 5(3):449-53. PubMed ID: 16911948
[TBL] [Abstract][Full Text] [Related]
3. Methylation-associated silencing of death-associated protein kinase gene in laryngeal squamous cell cancer.
Kong WJ; Zhang S; Guo C; Zhang S; Wang Y; Zhang D
Laryngoscope; 2005 Aug; 115(8):1395-401. PubMed ID: 16094112
[TBL] [Abstract][Full Text] [Related]
4. Promoter methylation of death-associated protein kinase and its role in irradiation response in cervical cancer.
Leung RC; Liu SS; Chan KY; Tam KF; Chan KL; Wong LC; Ngan HY
Oncol Rep; 2008 May; 19(5):1339-45. PubMed ID: 18425396
[TBL] [Abstract][Full Text] [Related]
5. [Hypermethylation of the death-associated protein kinase promoter in laryngeal squamous cell cancer].
Zhang S; Kong WJ
Zhonghua Zhong Liu Za Zhi; 2004 Aug; 26(8):469-71. PubMed ID: 15555335
[TBL] [Abstract][Full Text] [Related]
6. Epigenetic regulation of death-associated protein kinase expression in primary gastric cancers from Chinese patients.
Ye M; Li D; Zhou F; Guo Q; Xia B
Eur J Cancer Prev; 2012 May; 21(3):241-6. PubMed ID: 21979297
[TBL] [Abstract][Full Text] [Related]
7. Reduced expression of death-associated protein kinase in human uterine and ovarian carcinoma cells.
Bai T; Tanaka T; Yukawa K; Maeda M; Umesaki N
Oncol Rep; 2004 Mar; 11(3):661-5. PubMed ID: 14767518
[TBL] [Abstract][Full Text] [Related]
8. Urothelial carcinomas arising in arsenic-contaminated areas are associated with hypermethylation of the gene promoter of the death-associated protein kinase.
Chen WT; Hung WC; Kang WY; Huang YC; Chai CY
Histopathology; 2007 Dec; 51(6):785-92. PubMed ID: 17953697
[TBL] [Abstract][Full Text] [Related]
9. Death-associated protein kinase (DAPK) promoter methylation and response to neoadjuvant radiochemotherapy in esophageal cancer.
Brabender J; Arbab D; Huan X; Vallböhmer D; Grimminger P; Ling F; Neiss S; Bollschweiler E; Schneider PM; Hölscher AH; Metzger R
Ann Surg Oncol; 2009 May; 16(5):1378-83. PubMed ID: 19224282
[TBL] [Abstract][Full Text] [Related]
10. Aberrant methylation of DAPK in long-standing ulcerative colitis and ulcerative colitis-associated carcinoma.
Kuester D; Guenther T; Biesold S; Hartmann A; Bataille F; Ruemmele P; Peters B; Meyer F; Schubert D; Bohr UR; Malfertheiner P; Lippert H; Silver AR; Roessner A; Schneider-Stock R
Pathol Res Pract; 2010 Sep; 206(9):616-24. PubMed ID: 20630662
[TBL] [Abstract][Full Text] [Related]
11. Correlation between promoter methylation of p14(ARF), TMS1/ASC, and DAPK, and p53 mutation with prognosis in cholangiocarcinoma.
Xiaofang L; Kun T; Shaoping Y; Zaiqiu W; Hailong S
World J Surg Oncol; 2012 Jan; 10():5. PubMed ID: 22230750
[TBL] [Abstract][Full Text] [Related]
12. Positive correlation of tissue inhibitor of metalloproteinase-3 and death-associated protein kinase hypermethylation in head and neck squamous cell carcinoma.
Nayak CS; Carvalho AL; Jeronimo C; Henrique R; Kim MM; Hoque MO; Chang S; Jiang WW; Koch W; Westra W; Sidransky D; Califano J
Laryngoscope; 2007 Aug; 117(8):1376-80. PubMed ID: 17592394
[TBL] [Abstract][Full Text] [Related]
13. DAPK promotor methylation is an early event in colorectal carcinogenesis.
Mittag F; Kuester D; Vieth M; Peters B; Stolte B; Roessner A; Schneider-Stock R
Cancer Lett; 2006 Aug; 240(1):69-75. PubMed ID: 16246486
[TBL] [Abstract][Full Text] [Related]
14. Promoter methylation and down-regulation of DAPK is associated with gastric atrophy.
Kim WS; Son HJ; Park JO; Song SY; Park C
Int J Mol Med; 2003 Dec; 12(6):827-30. PubMed ID: 14612952
[TBL] [Abstract][Full Text] [Related]
15. Promoter methylation of RASSF1A, RARbeta and DAPK predict poor prognosis of patients with malignant mesothelioma.
Fischer JR; Ohnmacht U; Rieger N; Zemaitis M; Stoffregen C; Kostrzewa M; Buchholz E; Manegold C; Lahm H
Lung Cancer; 2006 Oct; 54(1):109-16. PubMed ID: 16893590
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of DAPK gene methylation and HPV and EBV infection in cervical cells from patients with normal cytology and colposcopy.
Lattario F; Furtado YL; Silveira FA; do Val IC; Almeida G; da Costa Carvalho Mda G
Arch Gynecol Obstet; 2008 Jun; 277(6):505-9. PubMed ID: 18026971
[TBL] [Abstract][Full Text] [Related]
17. mRNA expression profiles of methylated APAF-1 and DAPK-1 tumor suppressor genes uncover clear cell renal cell carcinomas with aggressive phenotype.
Christoph F; Hinz S; Kempkensteffen C; Schostak M; Schrader M; Miller K
J Urol; 2007 Dec; 178(6):2655-9. PubMed ID: 17945286
[TBL] [Abstract][Full Text] [Related]
18. Promoter hypermethylation of multiple genes in early gastric adenocarcinoma and precancerous lesions.
Zou XP; Zhang B; Zhang XQ; Chen M; Cao J; Liu WJ
Hum Pathol; 2009 Nov; 40(11):1534-42. PubMed ID: 19695681
[TBL] [Abstract][Full Text] [Related]
19. Can aberrant promoter hypermethylation of CpG islands predict the clinical outcome of non-small cell lung cancer after curative resection?
Kim YT; Lee SH; Sung SW; Kim JH
Ann Thorac Surg; 2005 Apr; 79(4):1180-8; discussion 1180-8. PubMed ID: 15797047
[TBL] [Abstract][Full Text] [Related]
20. Methyl-CpG binding protein MBD2 is implicated in methylation-mediated suppression of miR-373 in hilar cholangiocarcinoma.
Chen Y; Gao W; Luo J; Tian R; Sun H; Zou S
Oncol Rep; 2011 Feb; 25(2):443-51. PubMed ID: 21165562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
